LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Olema Oncology (NASDAQ: OLMA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ OLMA Olema Oncology
Myles David C. / officer: CH. DISCOV. & NON-CLIN DEV OFF
02/28/2025
Buy
$4.37
205,000
$896K
205,000
NASDAQ OLMA Olema Oncology
Zojwalla Naseem / officer: CHIEF MEDICAL OFFICER
02/28/2025
Buy
$4.37
205,000
$896K
205,000
NASDAQ OLMA Olema Oncology
Mitchell Shawnte / officer: CHIEF LEGAL OFFICER
02/28/2025
Buy
$4.37
450,000
$1.967M
450,000
NASDAQ OLMA Olema Oncology
Kovacs Shane William Charles / officer: CH. OPERATING & FINANCIAL OFF.
02/28/2025
Buy
$4.37
320,000
$1.398M
320,000
NASDAQ OLMA Olema Oncology
Bohen Sean / director, officer: PRESIDENT AND CEO
02/28/2025
Buy
$4.37
650,000
$2.841M
650,000